Moderna Inc on Thursday cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issue
TipMeACoffeebeta
Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/EBPSIU4CJZPJDGFG46WZDQPWFI.jpg)
Ask TipMeACoffee AI
Latest on TipMeACoffee AI
More AI Answers
Moderna Inc on Thursday cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issue